Free Trial
NYSEAMERICAN:CRHM

CRH Medical (CRHM) Stock Price, News & Analysis

CRH Medical logo
$3.99 0.00 (0.00%)
As of 04/22/2021

About CRH Medical Stock (NYSEAMERICAN:CRHM)

Key Stats

Today's Range
$3.99
$4.00
50-Day Range
N/A
52-Week Range
$1.66
$4.01
Volume
388,400 shs
Average Volume
1.04 million shs
Market Capitalization
$285.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company also distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. It serves 70 ambulatory surgical/endoscopy centers in 14 states. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.

Receive CRHM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CRH Medical and its competitors with MarketBeat's FREE daily newsletter.

CRHM Stock News Headlines

CRH plc (CRH) Q2 2024 Earnings Call Transcript
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
CRH PLC American Depositary Shares (CRH)
CRH Medical Corp (CRHM)
See More Headlines

CRHM Stock Analysis - Frequently Asked Questions

CRH Medical's stock was trading at $3.99 at the beginning of 2025. Since then, CRHM stock has increased by 0.0% and is now trading at $3.99.
View the best growth stocks for 2025 here
.

CRH Medical Co. (NYSEAMERICAN:CRHM) posted its earnings results on Thursday, November, 12th. The company reported ($0.01) earnings per share for the quarter, meeting the consensus estimate of ($0.01). The business had revenue of $30.35 million for the quarter, compared to analysts' expectations of $29.50 million. CRH Medical had a negative trailing twelve-month return on equity of 3.37% and a negative net margin of 4.12%.

Shares of CRHM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CRH Medical investors own include CRH Medical (CRH), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), AcelRx Pharmaceuticals (ACRX), Ampio Pharmaceuticals (AMPE), Extreme Networks (EXTR) and Palatin Technologies (PTN).

Company Calendar

Last Earnings
11/12/2020
Today
4/24/2025

Industry, Sector and Symbol

Stock Exchange
NYSEAMERICAN
Sector
Medical
Industry
Health Services
Sub-Industry
Healthcare
Current Symbol
NYSEAMERICAN:CRHM
Previous Symbol
NYSEARCA:CRHM
CIK
N/A
Fax
N/A
Employees
133
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$3.77 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$120.39 million
Cash Flow
$0.99 per share
Price / Cash Flow
4.02
Book Value
$1.73 per share
Price / Book
2.31

Miscellaneous

Free Float
N/A
Market Cap
$285.76 million
Optionable
Not Optionable
Beta
2.41
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSEAMERICAN:CRHM) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners